Navigation Links
BioForm Medical Announces Extension of Lock-Up Period
Date:5/5/2008

SAN MATEO, Calif., May 5 /PRNewswire-FirstCall/ -- BioForm Medical, Inc. (Nasdaq: BFRM) announced today that lock-up agreements entered into with its underwriters in conjunction with its initial public offering will be extended 18 days beyond the Company's May 1, 2008 earnings release. The lock-up period was due to expire on May 3, but the Company's underwriting agreement provided for an extension, depending on the timing of BioForm Medical's quarterly earnings press release. The first sales of shares restricted by the underwriter's lock-up may take place on Tuesday, May 20, 2008. Approximately 33 million shares will become eligible for sale in the public market upon expiration of the underwriters' lock-up, of which approximately 10 million shares will be freely tradable under Rule 144(b) and the remainder will be held by affiliates and other stockholders subject to the volume and other restrictions of Rule 144.

An additional number of shares equal to less than 5.0% of the shares outstanding prior to the November 2007 initial public offering were either not subject to a lock-up agreement or were subject to a lock-up agreement with the Company, the terms of which were less restrictive than the lock-up agreement with the underwriters, and, as such, became freely tradeable on May 5, 2008.

About BioForm Medical, Inc.:

BioForm Medical, Inc. is a medical aesthetics company headquartered in San Mateo, California, developing products that enhance aesthetic procedures performed in dermatology and plastic surgery practices. BioForm's lead product is Radiesse(R), a long-lasting dermal filler for use in facial aesthetics. BioForm is developing several future aesthetics products including a nerve ablation device for frown lines, a
'/>"/>

SOURCE BioForm Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology
2. BioForm Medical to Announce Financial Results For Quarter Ended March 31, 2008, Third Quarter of Fiscal 2008, and Host Conference Call and Webcast on May 1, 2008
3. BioForm Announces Financial Results for Quarter Ended December 31, 2007, Second Quarter of Fiscal 2008
4. BioForm to Announce First Quarter Fiscal 2008 Financial Results and Host Conference Call and Webcast on December 13, 2007
5. Federation of State Medical Boards Takes Interim Steps Toward Maintenance of Licensure Model Policy
6. Lombard Makes Investment in The Medical City, a Leading Philippine Hospital and Healthcare Provider
7. Game-Based Technology to Meet Demand for Improved Medical Teaching and Training
8. New Medical Technology is Changing the Face of Wrinkle Treatment
9. Cardiva Medical, Inc. Completes $15.5 Million Private Equity Financing
10. China Sky One Medical, Inc. Successfully Develops Semi-Quantitative Automatic Inspection Device for Diagnostic Kits
11. Shanghai Medical Technology Co., Ltd. Completes Merger With Aamaxan Transport Group, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... new study challenges the widely held belief that light drinking ... analyzed more than 50 studies that examined drinking habits and ... that those with a form of a gene tied to ... affects how a person,s body breaks down alcohol, resulting in ... variant has been shown to lead to lower drinking over ...
(Date:7/11/2014)... Recent research findings regarding Fourth Phase Water are ... water affects human bodies. That was the conclusion of the ... on the Sharon Kleyne Hour Power of Water radio show ... PhD, is a Professor of Bioengineering at the University of ... (Ebner & Sons, 2013). , “Fourth Phase Water,” ...
(Date:7/11/2014)... Alliance Labs announced that they will ... Ed Begley Jr, airing later this year 2014, via ... this episode, Innovations will explore DocuSol® Kids, a mini-enema ... polyethylene glycol base designed to give adolescents general constipation ... as a hyperosmotic laxative by drawing water into the ...
(Date:7/11/2014)... Re-tearing a repaired knee Anterior Cruciate Ligament ... being presented today at the American Orthopaedic Society for ... identification and patient education regarding modifiable risk factors may ... , “Our research suggests that a few risk factors ... utilized may point to the possibility of re-injury,” said ...
(Date:7/11/2014)... SEATTLE, WA Re-tearing a repaired knee Anterior Cruciate ... study being presented today at the American Orthopaedic Society ... and patient education regarding modifiable risk factors may minimize ... "Our research suggests that a few risk factors such ... may point to the possibility of re-injury," said lead ...
Breaking Medicine News(10 mins):Health News:A Little Alcohol May Not Be Good for Your Heart After All 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 2Health News:Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour 3Health News:Alliance Labs & DocuSol® to be Featured in Upcoming Episode of Innovations 2Health News:New Study May Identify Risk Factors for ACL Re-injury 2
... are soul sisters, says University of Illinois professor Constance ... pregnant and deliver babies that become the center of ... feel defeated and alone. Shapiro,s new book When ... that by providing a sisterhood of survivors who have ...
... more easily diagnosed and that its effects may be more ... in The FASEB Journal ( http://www.fasebj.org ), scientists ... and have discovered that drugs which affect the methylation state ... of drug is already being used in some cancer treatments. ...
... and shampoos, for instance, to breast development, , THURSDAY, ... in a wide range of consumer products may lead ... their risk for health problems later in life, U.S. ... -- phenols, phthalates and phytoestrogens -- are known as ...
... , ... is a great travel booking website for the vacationer who plans in advance, looking for ... a last-minute specials and deals. , ... Los Angeles, CA (PRWEB) April 8, 2010 -- SVH Tours & Travel, a ...
... prescription drugs , THURSDAY, April 8 (HealthDay News) -- Medical ... included -- are poorly informed about herbal medicines and that ... misplaced, according to a new survey. , The survey was ... and Therapeutics Bulletin , which published the results online April ...
... Thomas Mower Sr., Chairman of ... in the growth and success of Sportsmen for Fish and Wildlife (SFW), according to Founder Don ... Salt Lake City (PRWEB) April ... of the Utah Jazz, have been key players in the growth and success of Sportsmen for ...
Cached Medicine News:Health News:The Scarlet I: Infertility survivors lend voices to U of I prof's new book 2Health News:New study of autism reveals a 'DNA tag' (methylation) amenable to treatment 2Health News:Chemicals in Beauty Products Tied to Early Puberty in Girls 2Health News:Agency Pioneer SVH Tours & Travel Launches AppleSpecials.com, New Travel Booking Web Site that Showcases First-Hand Videos and Last Minute Specials 2Health News:Agency Pioneer SVH Tours & Travel Launches AppleSpecials.com, New Travel Booking Web Site that Showcases First-Hand Videos and Last Minute Specials 3Health News:Insight on Herbals Eludes Doctors, Patients Alike 2Health News:Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization 2Health News:Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization 3Health News:Thomas E. Mower And Karl Malone Instrumental To Success Of Sportsmen For Fish And Wildlife Organization 4
(Date:7/10/2014)... , July 10, 2014   Ventana Medical ... today announced it has entered into an agreement with ... operates as EMD Serono in the United ... to collaborate with Merck KGaA,s biopharmaceutical division on the ... an undisclosed target using Ventana,s proprietary diagnostic assays. In ...
(Date:1/15/2014)... Jan. 15, 2014 Sono-Tek Corporation (OTC BB: SOTK) today ... 30, 2013, compared to sales of $2,202,000 for the prior ... this quarter has also shown growth over the preceding quarter,s ... of this fiscal year. Markets that experienced sales increases over ...
(Date:1/15/2014)... today announced it has established a relief fund ... that has gripped much of the nation. AARP and its ... support these emergency relief efforts AARP and AARP Foundation will ... to $500,000 in aid. The matching program will be administered ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3Sono-Tek Announces Third Quarter Results 2Sono-Tek Announces Third Quarter Results 3Sono-Tek Announces Third Quarter Results 4AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... July 28 HemaQuest Pharmaceuticals, a clinical stage ... disease, beta thalassemia and EBV-related cancers, announced today the ... Series B financing by new investor, Latterell Venture Partners. ... $16M . The financing is intended to help ...
... DIEGO , July 27, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: ... MAC: Management Access Conference in New York on Tuesday, August ... PT .   Alex Casdin , vice president, finance of Amylin ... , , ...
Cached Medicine Technology:HemaQuest Pharmaceuticals Raises Additional $4M to Bring Total to $16M in Series B Financing 2Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Conference 2010 2
Full automatic, ready-to-use strip washer....
MultiWash Advantage is a versatile microplate washer engineered for reliability. It is designed for lab environments to help streamline their daily processes....
Synchron Hemoglobin A1c (HbA1c) utilizes two unique cartridges, Hb and A1c, to determine HbA1c concentration as a percentage of total hemoglobin....
... HbA1c Testing , Monoclonal antibody ... precision , Correlation study shows 99% agreement ... you can count on a CV ... , National Glycohemoglobin Standardization Program (NGSP) certified ...
Medicine Products: